Isabella Ciccone, Associate Editor, NeurologyLive®, has been with the team since September 2022. Follow her on Twitter @iciccone7 or email her at iciccone@mjhlifesciences.com
Impact of COVID-19 Vaccination on Neurologic Manifestations of Long COVID: Igor Koralnik, MD
January 14th 2025The chief of neuroinfectious diseases and global neurology at Northwestern Medicine discussed a recently published study that highlighted Long COVID’s significant clinical and societal impact. [WATCH TIME: 5 minutes]
Understanding Lifetime Risk and the Rising Burden of Dementia: Josef Coresh, MD, PhD
January 14th 2025The founding director of the Optimal Aging Institute at the NYU Grossman School of Medicine talked about a recent study that estimated the lifetime risk of dementia and its implications for prevention, care, as well as societal planning. [WATCH TIME: 5 minutes]
Advancing Understanding of the Preclinical Phase of Multiple Sclerosis: Christina J. Azevedo, MD
January 13th 2025At the 2024 ECTRIMS Congress, the associate professor of clinical neurology at Keck School of Medicine of USC talked about recent research that highlights the preclinical phase of multiple sclerosis. [WATCH TIME: 9 minutes]
Overlapping Diagnoses and the Advancement of MS Detection in NMDARE: Joseph Kuchling, MD
January 7th 2025The postdoctoral research assistant at Charité University Berlin discussed advances in diagnostic criteria and 7-Tesla MRI imaging, highlighting a previously overlooked overlap between anti-N-methyl-D-aspartate receptor encephalitis and multiple sclerosis. [WATCH TIME: 5 minutes]
FDA Removes Partial Clinical Hold on VG-3927 for Microglial Dysfunction in Alzheimer Disease
January 6th 2025Results from Vigil Neuroscience’s ongoing phase 1 trial of VG-3927 in healthy volunteers supported the continued development of the therapy as a potential once-daily oral treatment for Alzheimer disease.
Evolving MS Diagnostics From Categorical Classifications to Biological Phenotyping: Fred Lublin, MD
January 3rd 2025The director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai talked about the shift in multiple sclerosis diagnostics from rigid classification systems to a dynamic, spectrum-based approach focused on biological phenotyping. [WATCH TIME: 5 minutes]
Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision
December 24th 2024With new revisions of the MS diagnostic criteria being made, clinicians highlighted key updates and the broader implications it has for diagnosis, treatment, and healthcare practices worldwide.
Syn-One Test Displays Significant Clinical Utility for the Diagnosis of Synucleinopathies
December 22nd 2024Since the Syn-One Test only needs a small punch skin biopsy that can be collected in an office setting, the clinical utility can be enhanced to offer more geographically convenient access for patients earlier in the disease.